| Active substance |
Cephalexin |
| Also known as |
Cephalexin |
| Blood pressure |
No significant impact |
| Chemical name |
(6R,7R)-3-Methyl-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Dosage (medical) |
Typically 250 mg to 500 mg every 6 hours or 500 mg every 12 hours, depending on the severity of the infection |
| Dosage (sports) |
Not applicable |
| Effects |
Effective against bacterial infections, particularly in skin, bone, and urinary tract infections |
| Formula |
C16H17N3O4S |
| Half-life |
Approximately 1 hour |
| Hepatotoxicity |
Rare |
| Lab Test |
No specific lab test influenced by this drug |
| Main action |
Bactericidal, inhibits bacterial cell wall synthesis |
| Side effects |
Diarrhea, nausea, vomiting, rash, and allergic reactions |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
250mg |
| Substance class |
Antibiotic, specifically a first-generation cephalosporin |
| Trade name |
Keflex, others |
| Use in sports |
Not typically used in sports, no performance-enhancing effects |
| Water Retention |
No significant effect |
| Manufacturer |
Cipla Ltd. |
| Packing |
10 caps/blister |
